These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6491946)

  • 1. Kinetics of aspirin absorption following oral administration of six aqueous solutions with different buffer capacities.
    Mason WD
    J Pharm Sci; 1984 Sep; 73(9):1258-61. PubMed ID: 6491946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative aspirin absorption kinetics after administration of sodium- and potassium-containing buffered solutions.
    Mason WD
    J Pharm Sci; 1984 Jul; 73(7):998-9. PubMed ID: 6470971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of food on aspirin absorption from tablets and buffered solutions.
    Mason WD; Winer N
    J Pharm Sci; 1983 Jul; 72(7):819-21. PubMed ID: 6886992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of aspirin, salicylic acid, and salicyluric acid following oral administration of aspirin as a tablet and two buffered solutions.
    Mason WD; Winer N
    J Pharm Sci; 1981 Mar; 70(3):262-5. PubMed ID: 7264888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antacids on salicylate kinetics.
    Shastri RA
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):480-4. PubMed ID: 4055159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of salicylic acid following administration of aspirin tablets and three different forms of soluble aspirin in normal subjects.
    Gatti G; Barzaghi N; Attardo Parrinello G; Vitiello B; Perucca E
    Int J Clin Pharmacol Res; 1989; 9(6):385-9. PubMed ID: 2517497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of the salicylates.
    Needs CJ; Brooks PM
    Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, and effect on gastric mucosa, of buffered and non-buffered tablets of acetylsalicylic acid.
    Linnoila M; Lehtola J
    Int J Clin Pharmacol Biopharm; 1977 Feb; 15(2):61-4. PubMed ID: 885664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward Biopredictive Dissolution for Enteric Coated Dosage Forms.
    Al-Gousous J; Amidon GL; Langguth P
    Mol Pharm; 2016 Jun; 13(6):1927-36. PubMed ID: 27139040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
    Lui CY; Oberle R; Fleisher D; Amidon GL
    J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
    Lin MS; Sun P; Yu HY
    J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal absorption of aspirin. Influence of pH, taurocholate, ascorbate, and ethanol.
    Hollander D; Dadufalza VD; Fairchild PA
    J Lab Clin Med; 1981 Oct; 98(4):591-8. PubMed ID: 7288271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of aspirin.
    Levy G
    Pediatrics; 1978 Nov; 62(5 Pt 2 Suppl):867-72. PubMed ID: 724339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability studies on a buffered acetylsalicylic acid preparation.
    Ekenved G; Elofsson R; Sölvell L
    Acta Pharm Suec; 1975; 12(4):323-32. PubMed ID: 1106118
    [No Abstract]   [Full Text] [Related]  

  • 16. Extrahepatic metabolism and distribution of aspirin in vascular beds of sheep.
    Cossum PA; Roberts MS; Kilpatrick D; Yong AC
    J Pharm Sci; 1986 Aug; 75(8):731-7. PubMed ID: 3772743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the influence of media composition and ionic strength on drug release from commercial immediate-release and enteric-coated aspirin tablets.
    Karkossa F; Klein S
    J Pharm Pharmacol; 2017 Oct; 69(10):1327-1340. PubMed ID: 28703304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter- and intraindividual variation in absorption from tablets and solutions in man.
    Frislid K; Haram EM; Norberg R; Oie S
    Pharm Acta Helv; 1973; 48(11):610-21. PubMed ID: 4783901
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of food on the absorption of enteric-coated aspirin: correlation with gastric residence time.
    Mojaverian P; Rocci ML; Conner DP; Abrams WB; Vlasses PH
    Clin Pharmacol Ther; 1987 Jan; 41(1):11-7. PubMed ID: 3802700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of aspirin in rats and the effect of buffer.
    Fu CJ; Melethil S; Mason WD
    J Pharmacokinet Biopharm; 1991 Apr; 19(2):157-73. PubMed ID: 2013838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.